I. L. do N. Neres, R. O. Mello,  JúliaS.Bernardes, and J. de S. P. Barbosa, “RISK OF CARDIOVASCULAR DISEASE ASSOCIATED WITH THE HALOPERIDOL USE IN PATIENTS WITH SCHIZOPHRENIA”, REASE, vol. 12, no. 8, pp. 1–27, Aug. 2026, doi: 10.51891/rease.v12i8.28165.